1832 related articles for article (PubMed ID: 27072860)
1. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
2. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F
BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157
[TBL] [Abstract][Full Text] [Related]
4. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.
Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423
[TBL] [Abstract][Full Text] [Related]
5. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
7. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
Legris V; Thibault B; Dupuis J; White M; Asgar AW; Fortier A; Pitre C; Bouabdallaoui N; Henri C; O'Meara E; Ducharme A;
ESC Heart Fail; 2022 Feb; 9(1):450-464. PubMed ID: 34953062
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
[TBL] [Abstract][Full Text] [Related]
12. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction: Role of Pulmonary Vascular Dysfunction.
Singh I; Rahaghi FN; Naeije R; Oliveira RKF; Systrom DM; Waxman AB
Chest; 2019 Nov; 156(5):933-943. PubMed ID: 31103695
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circulation; 2011 Jul; 124(2):164-74. PubMed ID: 21709061
[TBL] [Abstract][Full Text] [Related]
14. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
[TBL] [Abstract][Full Text] [Related]
15. Left Atrial Function Dynamics During Exercise in Heart Failure: Pathophysiological Implications on the Right Heart and Exercise Ventilation Inefficiency.
Sugimoto T; Bandera F; Generati G; Alfonzetti E; Bussadori C; Guazzi M
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1253-1264. PubMed ID: 28017395
[TBL] [Abstract][Full Text] [Related]
16. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
17. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
AbouEzzeddine OF; Haines P; Stevens S; Nativi-Nicolau J; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
JACC Heart Fail; 2015 Mar; 3(3):245-52. PubMed ID: 25742762
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
20. The immediate effect of sildenafil on right ventricular function in patients with heart failure measured by cardiac magnetic resonance: a randomized control trial.
Fernandes AM; Andrade AC; Barroso ND; Borges IC; Carvalho-Andrade D; Rodrigues Junior ES; Guimarães LC; Durães AR; Borges SM; Aras Junior R
PLoS One; 2015; 10(3):e0119623. PubMed ID: 25793988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
